Ancora Heart kicked off a European clinical study for its device designed to directly repair an enlarged left ventricle from the inside, as a treatment for patients suffering from heart failure. The ...

Left ventricular remodeling is a key determinant of the clinical course and outcome of systolic heart failure. The myocardial renin–angiotensin system (RAS) has been closely linked to the major ...

Because life expectancy and the prevalence of risk factors such as hypertension, obesity and diabetes are rising globally, heart failure (HF) is growing into a major health problem. Impairment of left ...

Multicenter randomized trial (n=200) assigned LBBP versus BiVP for CRT in LBBB with LVEF ≤35%, using time to death or HF hospitalization as primary endpoint. Event rates favored LBBP, reducing death ...

New concepts in device therapy for advanced heart failure presented in early reports ...

CHICAGO, IL — AUGMENT HF, a phase 2 trial of 78 patients with advanced heart failure, showed that an injection of the novel hydrogel Algisyl-LVR hydrogel (LoneStar Heart, Dallas, TX) into their left ...

Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger predictor of coronary artery disease-related death and heart failure than coronary artery calcium score, according ...

Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ...

Respiratory sarcopenia, defined by low diaphragm thickness and reduced FVC, is associated with increased 2-year mortality in HF.

During embryonic development, the right ventricle is formed from the secondary heart field into a crescent-shaped, thin-walled structure. 6 It is the most anterior heart chamber, sitting just beneath ...